GLOBALLY RECOGNIZED EXPERTISE IN THE MANUFACTURING OF INJECTABLE PRODUCTS
Our Pau site is dedicated to the manufacture of injectable products with a high level of added value. It specializes in aseptic filling under isolators of cytotoxic and biotechnological anti-cancer products, the filling of bottles with liquids and lyophilisates, and pre-filled syringes. Its high-quality expertise is recognized throughout the world.
The site is certified by healthcare agencies in various regions: ANSM (France), EMA (Europe), FDA (United States) and PMDA (Japan).
The site was designed and built in 1991 to manufacture Navelbine, Pierre Fabre Laboratories’ new anti-cancer drug. Since then, the Pau site has developed a unique expertise in the manufacturing of highly-toxic anti-cancer drugs under cutting-edge isolator technology. In 2005, Pierre Fabre built a second site dedicated to the processing of lyophilisates and liquids for anti-cancer products.
EXPERTISE AVAILABLE TO THIRD PARTIES
For 20 years, the Pau site has worked for third-party laboratories in producing clinical and industrial batches and offering a tailored service to clients, for the manufacture of active substances for finished products. A team of experts is available to clients to evaluate the technological transfer of products and to offer a procedure that guarantees the production quality and capacity.